1. All Products
  2. DORA - Oral drugs
  3. ETHINYLESTR. 0.03mg / LEVONORGESTREL 0.15mg, blister 28 tab.
Public Pricelist

ETHINYLESTR. 0.03mg / LEVONORGESTREL 0.15mg, blister 28 tab.

https://medicalguidelines.msf.org/en/node/402
https://unicat.msf.org/cat/product/12029
STD DORAETHL31T

Valid Article

Former Code(s): DORAETHL3T1 1
22.1.1 - Oral hormonal contraceptives
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
G03AA07
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

ETHINYLESTRADIOL / LEVONORGESTREL

Full Name

Synonym: Combined Oral Contraceptives (COCs)

Therapeutic Action

Combinaison of two monophasic contraceptives: oestrogen (ethinylestradiol) and progestogen (levonorgestrel)

Instructions for use

The 28-tablets blister allows a better compliance:

  • 21 active tablets of 0.03 mg ethinylestradiol + 0.15 mg levonorgestrel
  • 7 inactive tablets (inactive hormone tablets containing ferrous salts are also accepted)

1 tablet to be taken every day at the same time.

Follow the recommendations of the national programme or the local customs.

The quantity to be ordered is calculated per blister (= one treatment), not per tablet.

Precautions for Use

COCs can be used during breastfeeding, but it is recommended to wait until at least 6 weeks after delivery before starting them (risk of blood clots).

Storage

Below 25ºC - Protect from sunlight